Generation Bio Statistics Share Statistics Generation Bio has 6.7M
shares outstanding. The number of shares has increased by 0.04%
in one year.
Shares Outstanding 6.7M Shares Change (YoY) 0.04% Shares Change (QoQ) 0.04% Owned by Institutions (%) 58.85% Shares Floating 4.58M Failed to Deliver (FTD) Shares 98,500 FTD / Avg. Volume 80.1%
Short Selling Information The latest short interest is 814.51K, so 12.16% of the outstanding
shares have been sold short.
Short Interest 814.51K Short % of Shares Out 12.16% Short % of Float 17.7% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.54 and the forward
PE ratio is -0.37.
Generation Bio's PEG ratio is
-0.53.
PE Ratio -0.54 Forward PE -0.37 PS Ratio 3.55 Forward PS 3.9 PB Ratio 0.82 P/FCF Ratio -0.78 PEG Ratio -0.53
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Generation Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.5,
with a Debt / Equity ratio of 1.09.
Current Ratio 5.5 Quick Ratio 5.5 Debt / Equity 1.09 Debt / EBITDA -1.26 Debt / FCF -1.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $172.97K Profits Per Employee $-1.14M Employee Count 115 Asset Turnover 0.09 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -82.94% in the
last 52 weeks. The beta is 2.67, so Generation Bio's
price volatility has been higher than the market average.
Beta 2.67 52-Week Price Change -82.94% 50-Day Moving Average 4.01 200-Day Moving Average 7.93 Relative Strength Index (RSI) 47.69 Average Volume (20 Days) 122,977
Income Statement In the last 12 months, Generation Bio had revenue of 19.89M
and earned -131.67M
in profits. Earnings per share was -19.8.
Revenue 19.89M Gross Profit 19.89M Operating Income -142.39M Net Income -131.67M EBITDA -74.26M EBIT -79.19M Earnings Per Share (EPS) -19.8
Full Income Statement Balance Sheet The company has 76.3M in cash and 93.56M in
debt, giving a net cash position of -17.26M.
Cash & Cash Equivalents 76.3M Total Debt 93.56M Net Cash -17.26M Retained Earnings -703.04M Total Assets 201.35M Working Capital 145.52M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -88.56M
and capital expenditures -2.4M, giving a free cash flow of -90.96M.
Operating Cash Flow -88.56M Capital Expenditures -2.4M Free Cash Flow -90.96M FCF Per Share -13.65
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -715.82% and -661.91%.
Gross Margin 100% Operating Margin -715.82% Pretax Margin -661.91% Profit Margin -661.91% EBITDA Margin -373.33% EBIT Margin -715.82% FCF Margin -457.29%
Dividends & Yields GBIO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for GBIO is $85,
which is 2019.7% higher than the current price. The consensus rating is "Buy".
Price Target $85 Price Target Difference 2019.7% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 22, 2025. It was a
backward
split with a ratio of 1:10.
Last Split Date Jul 22, 2025 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -5.08 Piotroski F-Score 2
